
Bioorganic and Medicinal Chemistry Letters p. 1791 - 1796 (1998)
Update date:2022-09-26
Topics:
Chambers
Antognoli
Cheng
Marfat
Pillar
Shirley
Watson
By addressing the issues of potency and metabolism in 3, a new series of LTD4 antagonists represented by (+)-26 was developed which is equipotent to clinical LTD4 antagonists Zafirlukast (1) and Pranlukast (2).
View Morewebsite:http://www.win-winchemical.com
Contact:0086-577-64498589
Address:6F, No. 396 Xingping Road, Longwan Industrial Zone, Wenzhou City, Zhejiang, 325000 P.R.China
Changzhou Kingyo Chemical Corporation Ltd.
website:http://www.kingyochem.com
Contact:+86-519-85105717
Address:19# Wuqing North Road, Changzhou , Jiangsu, China
Beyond Pharmaceutical Co., Ltd
Contact:+86-571-8195-3185
Address:No. 13-1, Liansheng Road, Yuhang District
Contact:+86-512-56795332
Address:No227 Shuanglong Rd, Fenghuang, Zhangjiagang
Contact:+86-838-5655598
Address:Guanghan Nanfeng Industrial Zone
Doi:10.1016/S0040-4039(97)01002-2
(1997)Doi:10.1039/a807718e
(1999)Doi:10.1002/hlca.19970800424
(1997)Doi:10.1021/acs.organomet.7b00603
(2018)Doi:10.1016/S0040-4020(97)00526-7
(1997)Doi:10.1021/jo970548x
(1997)